Free Daily Podcast Summary
JACC Global: Daily Summaries Delivered
by American College of Cardiology
Explore cardiovascular science from a global perspective with JACC Global. This podcast highlights original research, regional innovations, and urgent challenges in heart health across diverse healthcare settings worldwide.
Latest Episodes
The most recent episodes — sign up to get AI-powered summaries of each one.
- 4 days ago34 min
ICI Myocarditis: Does Timing Define the Disease? | JACC Baran
Is immune checkpoint inhibitor (ICI)-associated myocarditis the same disease when it occurs early versus months after starting cancer therapy? Host Mitsuaki Sawano, MD, and co-host Shun Kohsaka, MD, welcome Kazuaki Maruyama, MD (Mie University), Shiro Nakamori, MD (Mie University), and Yuichi Tamura, MD (International University of Health and Welfare) to discuss their recent JACC: CardioOncology study examining inflammatory cell profiles in early- and late-manifestation ICI myocarditis. Using endomyocardial biopsy specimens from 35 patients across 11 Japanese centers, the investigators found substantially greater T-cell and macrophage infiltration in early cases, while late-manifestation cases showed less myocardial inflammation despite similar fibrosis and LVEF. We discuss whether timing may identify different inflammatory phenotypes, why clinical severity does not necessarily reflect the degree of myocardial inflammation, and the difficult clinical question of whether ICI therapy should always be permanently discontinued after suspected myocarditis. Finally, we explore how Japan’s unique experience with myocardial biopsy helped uncover these differences and whether carefully selected patients with late, milder presentations might eventually be considered for ICI rechallenge, while recognizing the hypothesis-generating nature of these findings.
- 4 days ago34 min
ICI Myocarditis: Does Timing Define the Disease? | JACC Baran
Is immune checkpoint inhibitor (ICI)-associated myocarditis the same disease when it occurs early versus months after starting cancer therapy? Host Mitsuaki Sawano, MD, and co-host Shun Kohsaka, MD, welcome Kazuaki Maruyama, MD (Mie University), Shiro Nakamori, MD (Mie University), and Yuichi Tamura, MD (International University of Health and Welfare) to discuss their recent JACC: CardioOncology study examining inflammatory cell profiles in early- and late-manifestation ICI myocarditis. Using endomyocardial biopsy specimens from 35 patients across 11 Japanese centers, the investigators found substantially greater T-cell and macrophage infiltration in early cases, while late-manifestation cases showed less myocardial inflammation despite similar fibrosis and LVEF. We discuss whether timing may identify different inflammatory phenotypes, why clinical severity does not necessarily reflect the degree of myocardial inflammation, and the difficult clinical question of whether ICI therapy should always be permanently discontinued after suspected myocarditis. Finally, we explore how Japan’s unique experience with myocardial biopsy helped uncover these differences and whether carefully selected patients with late, milder presentations might eventually be considered for ICI rechallenge, while recognizing the hypothesis-generating nature of these findings.
- 1 weeks ago36 min
Does PFA Reach the Vein of Marshall? | JACC Baran
Does pulsed field ablation (PFA) for pulmonary vein isolation affect structures beyond the pulmonary veins? Host Mitsuaki Sawano, MD, welcomes Yosuke Nakatani, MD (Gunma University) to discuss his recent JACC: Clinical Electrophysiology study examining the effects of PFA on the vein of Marshall (VoM). In this prospective study of 72 patients undergoing PFA using three different systems, a microelectrode catheter was positioned within the VoM to continuously record electrograms during ablation. PFA acutely altered VoM electrograms in 44% of patients, including complete elimination in 22%, but persistent VoM modification remained in only 14% by the end of the procedure. Importantly, the effect was strongly related to the distance between the PFA electrode and the VoM, suggesting that catheter geometry and proximity may matter more than energy strength alone. We discuss what these findings reveal about the unintended collateral effects of PFA, why most acute VoM effects rapidly recover, whether PFA could ever replace ethanol infusion for VoM ablation, and how a research idea conceived during Dr. Nakatani’s fellowship in Bordeaux ultimately became a first-in-human mechanistic study in Japan.
- 2 weeks ago28 min
A SELUTION to Paclitaxel DCB Complications in PAD? | JACC Baran
Could sirolimus-coated balloons change how we treat femoropopliteal peripheral artery disease? Host Mitsuaki Sawano, MD, welcomes Yoshimitsu Soga, MD, PhD (Kokura Memorial Hospital) to discuss the 3-year results of the SELUTION SFA Japan study, a prospective multicenter study of 134 patients with symptomatic femoropopliteal disease treated with a novel sirolimus-eluting balloon. Despite relatively complex lesions, the study showed encouraging long-term outcomes, with particularly few additional restenosis and target lesion revascularization events after the first year. We discuss why sirolimus may offer an alternative to paclitaxel, how sustained drug delivery makes a sirolimus-coated balloon possible, and what the recently published SIRONA randomized trial adds to the evolving evidence comparing sirolimus- and paclitaxel-coated balloons. Finally, we look ahead to whether sirolimus DCBs could reshape PAD intervention and what the peripheral experience might eventually teach us about coronary DCB therapy.
- 3 weeks ago35 min
Proteomics in Action: Finding the Right Drug Targets for Ischemic Heart Disease | JACC Baran
Which of the thousands of biomarkers associated with cardiovascular disease could actually become a useful drug target? Host Mitsuaki Sawano, MD, and co-host Nobuhiro Ikemura, MD, welcome Satoshi Yoshiji, MD, PhD (McGill University) to discuss a recent JACC study tackling this question in ischemic heart disease. Starting with 9,520 circulating proteins, the investigators used human genetics to move beyond association toward stronger evidence for causality, combining Mendelian randomization, genetic colocalization, multiple proteomic platforms, and cross-ancestry validation to narrow thousands of signals to a small group of potential therapeutic targets. We break down what these methods actually mean for clinicians: what cis-pQTLs tell us, why MR alone is not enough, what colocalization adds, and why validation across platforms and populations matters. The episode explores how this emerging approach could help determine which biological targets are worth pursuing in drug development and ultimately testing in clinical trials.
- Oct 6, 202636 min
PET Unmasks CMD: The Hidden Risk Behind Normal Perfusion | JACC Baran
Hosts Mitsuaki Sawano, MD, Satoshi Shoji, MD, and Kentaro Ejiri, MD, welcome Yoshito Kadoya, MD, PhD (University of British Columbia / St. Paul’s Hospital) to discuss his JACC: Cardiovascular Imaging study, “PET-Based Coronary Microvascular Dysfunction Phenotypes and Outcomes in Patients With Normal Myocardial Perfusion.” Among 3,317 patients with normal relative perfusion on cardiac PET, the study examined four phenotypes defined by myocardial flow reserve and stress myocardial blood flow. Both classical CMD and endogen CMD were associated with higher long-term cardiovascular risk, suggesting that reduced MFR may remain clinically meaningful even when stress myocardial blood flow is preserved. The episode explores how PET can phenotype coronary microvascular dysfunction, differences between invasive and noninvasive approaches to CMD, and Dr. Kadoya’s cardiac imaging training and career in Canada.
- Sep 29, 202639 min
Rethinking Health Care at Home and Abroad: Lancet RH Western Pacific Special | JACC Baran
Host Mitsuaki Sawano, MD, welcomes Shuhei Nomura, PhD (Tohoku University), Lisa Yamasaki, MD (Harvard T.H. Chan School of Public Health), and Haruka Sakamoto, MD, PhD (St. Luke’s International Hospital) to discuss two policy reviews published in The Lancet Regional Health – Western Pacific. Fifteen years after the 2011 Lancet Japan Series, Japan faces population aging, rising long-term care needs, workforce shortages, financial pressures, and a rapidly changing global health environment. The episode explores how Japan can shift from hospital-centered care toward prevention and community-based care while also rethinking its role in global health. The guests discuss why domestic reform and international collaboration must increasingly move together, and what Japan can learn from its neighbors as it prepares for 2040.
- Sep 22, 202636 min
PFA Changes the Game and the AT Circuit | JACC Baran
Hosts Mitsuaki Sawano, MD, and Hiroyuki Sato, MD, welcome Kazutaka Nakasone, MD (Kobe University) to discuss his JACC: Clinical Electrophysiology study on atrial tachycardia (AT) after pulsed field ablation (PFA) for atrial fibrillation. In a 5-center European registry of 4,144 patients, 76 (1.8%) underwent repeat ablation for AT. Most ATs were left atrial macroreentrant tachycardias, with approximately 86% involving dual-loop circuits. The episode explores why comprehensive left atrial mapping may be key to selecting the optimal ablation line, the impact of PVI versus posterior wall isolation, and the potential role of 3D mapping. Dr. Nakasone also shares how the study grew from his fellowship in Brussels and his experience training in Belgium.
Get JACC Global summaries in your inbox
Free AI-powered daily recaps. Key takeaways, quotes, and mentions — in a 5-minute read.
Get Free Summaries →Free forever for up to 3 podcasts. No credit card required.
You Might Also Like
Listeners also like.
The Internet Book of Critical Care Podcast
A podcast exploring critical care medicine through chapter discussions and evidence-based updates from The Internet Book of Critical Care.
This Week in Cardiology
A weekly summary and analysis of key developments in cardiology for healthcare professionals.
In the Interim...
Explores Bayesian statistics and adaptive clinical trial designs in medical research with insights from industry experts.
ICU Ed and Todd-Cast
Eddie and Todd
The Peter Attia Drive
Conversations with experts on health, longevity, performance, and critical thinking led by physician Peter Attia.
Extend Podcast with Darshan Shah, MD
Explores science-backed strategies and expert insights to extend healthspan and optimize longevity through actionable health protocols.
The Curbsiders Internal Medicine Podcast
Expert-led internal medicine discussions with clinical insights and humor for primary care and hospital medicine providers.
Health vs Hype with the American Medical Association
A medical expert debunks viral health trends and misinformation with science-backed insights from physicians.
JOSPT Insights
JOSPT
Get Better Faster
Doctors and researchers discuss functional medicine and root-cause approaches to chronic illness and health optimization.
The Health Continuum
High-performing professionals learn science-based health strategies to sustain energy, focus, and resilience in demanding careers.
A Shot in the Arm Podcast
Ben Plumley
About JACC Global
Explore cardiovascular science from a global perspective with JACC Global. This podcast highlights original research, regional innovations, and urgent challenges in heart health across diverse healthcare settings worldwide.
Customized Recaps
AI-powered recaps with compact key takeaways, quotes, and insights.
Straight to Your Inbox
Get key takeaways from JACC Global in a 5-minute read.
Save Hours Every Week
Stay current on your favorite podcasts without falling behind.
Frequently Asked Questions
What is Podzilla's JACC Global daily summary?
It's a free AI-powered email that summarizes new episodes of JACC Global as soon as they're published. You get the key takeaways, notable quotes, and links & mentions — all in a quick read.
How does the JACC Global podcast summary work?
When a new episode drops, our AI transcribes and analyzes it, then generates a personalized summary tailored to your interests and profession. It's delivered to your inbox every morning.
Is this an official JACC Global product?
No. Podzilla is an independent service that summarizes publicly available podcast content. We're not affiliated with or endorsed by American College of Cardiology.
Can I get summaries of other podcasts too?
Absolutely! The free plan covers up to 3 podcasts, any in the catalog. Basic raises that to 15, Pro to 40 and Max to 100. Browse our full catalog at /podcasts.
How often does JACC Global release new episodes?
JACC Global publishes weekly. Our AI generates a summary within hours of each new episode.
What topics does JACC Global cover?
JACC Global covers topics including Medicine, Fitness, Health & Fitness. Our AI identifies the specific themes in each episode and highlights what matters most to you.
Start getting JACC Global summaries tomorrow morning.
Free forever for up to 3 podcasts. No credit card required.
Free forever for up to 3 podcasts. No credit card required.